David Sides - 29 Jul 2021 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
Chief Operating Officer
Signature
/s/ Adam C. Vandervoort, attorney-in-fact
Issuer symbol
TDOC
Transactions as of
29 Jul 2021
Transactions value $
-$527,966
Form type
4
Filing time
02 Aug 2021, 16:10:47 UTC
Next filing
24 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +7.3K +102.06% 14.5K 29 Jul 2021 Direct F1
transaction TDOC Common Stock Sale -$528K -3.42K -23.67% $154.38 11K 30 Jul 2021 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Restricted Stock Units Options Exercise $0 -7.3K -50% $0.00 7.3K 29 Jul 2021 Common Stock 7.3K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 On July 30, 2019, the reporting person was granted 21,897 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.
F3 Shares sold to cover the issuer's withholding obligation in respect of reporting person's award.